Among the 14 genes, BRCA1 is associated with DNA damage repair, and its low expression may enhance tumor cell sensitivity to treatment (Yoshida and Miki, 2004); conversely, high Wnt3A expression may promote tumor cell proliferation and differentiation, correlating with poorer pathological response and prognosis (Lin and Liu, 2021). Here, WNT3A is linked to neoplasm.